Universal NutriScience (UNS) on Monday announced the appointment of Pratin Vete as its Chief Executive Officer.
Vete has over 30 years of experience in the pharmaceutical industry and a foundation in business development, strategic planning and implementation, according to a statement.
Prior to joining UNS, Vete led the Rs 2,000 crore India formulations business at Emcure Pharmaceuticals. As President, he was responsible for strategy and business transformation across multiple therapeutic categories with 3,000 strong sales force while navigating through the Covid-19 pandemic.
Previously, Vete led the Rs 1,600 crore chronic care business in Cipla with a team of 3,000 people. He has also held senior positions of increasing responsibilities in Sanofi India.
Nutraceuticals is a growing segment in the Indian Healthcare scenario and Vete’s joining will bolster UNS’ commitment towards creating new nutraceutical categories and drug delivery systems which will help consumers lead healthier life, as per the statement.
Dr Shailesh Ayyangar, Chairman of the Board, UNS and Annaswamy Vaidheesh, Director, UNS, said, “We are delighted to welcome Pratin to the team, whose expertise will help us accelerate the growth and create a stronger positioning for UNS in the nutraceuticals market. His vast experience in leadership roles augurs well with the fast growing UNS team of professionals. Vete’s warm and composed nature fits well with UNS’s people-first culture, which will, in turn, help the company to attract, manage, and retain the best talent in the industry.”
Vikram Tannan, Founder, Universal Medicare and Nishant Sharma, CIO & Managing Partner of Kedaara Capital, said, “The nutraceutical market in India is a large and rapidly growing opportunity with rising awareness and demand. UNS is suitably placed to become the leader in the nutraceutical market through product innovation and by increasing awareness through digital channels. We see a strong partner in Pratin whom we can leverage to scale up our business and garner visibility for our products among our customers, stakeholders, and distributors.”
Pratin Vete, CEO, Universal NutriScience, said, “I am delighted to be a part of the growth journey of UNS which is making commendable contributions to the nutraceuticals industry. My passion for healthcare and experience across therapy areas makes it even more fascinating to partner with a brand that is invested in superior R&D, state-of-the art manufacturing, and evidence-based medicine. Together, we will work towards making UNS the leader of nutraceuticals, bringing holistic healthcare to the country.”
Vete holds a BSc in Physics and has pursued his Master of Management Studies with a specialisation in Marketing from the University of Mumbai.
UNS is a nutraceutical company that delivers nutraceutical and lifestyle products. It was created through a strategic partnership between Kedaara Capital, a private equity Indian firm and Universal Medicare, an Indian nutraceuticals company.